Selective inhibitors of nuclear export (SINE) as novel therapeutics for prostate cancerJanet Mendonca, Sushant K. Kachhap|Oncotarget|2014Cited by 63
Combining the pan‐aurora kinase inhibitor <scp>AMG</scp> 900 with histone deacetylase inhibitors enhances antitumor activity in prostate cancerChanning J. Paller, Sushant K. Kachhap|Cancer Medicine|2014Cited by 30